EUVIMEDEUVIMED entdecken
Zurückgezogene PublikationOpen Access · CC BY 4.0

RETRACTED: Oxaliplatin activates P53/miR‐34a/survivin axis in inhibiting the progression of gastric cancer cells

Qiang Guo, Xin-Yuan Wang, Yan-Chang Zhai, Yong-Wei Dong, Qing-Si He iD

Immunity, Inflammation and Disease · 2024

DOI: 10.1002/iid3.70004 ↗

Kurz gefasst

Zurückgezogene Publikation in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Qiang Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital of Baotou Medical College, Baotou, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, MicroRNAs, Oxaliplatin, Survivin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Inner Mongolia Autonomous Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The purpose of this research was to determine how the P53/microRNA‐34a (miR‐34a)/survivin pathway contributes to oxaliplatin‐induced (L‐OHP) cell inhibition in gastric cancer.

Methods

The BGC‐823 gastric cancer cells were selected, and we examined their viability following treatment with L‐OHP at different concentrations and time periods. The expression levels of miR‐34a, P53, and survivin in the cells were determined.

Results

In the 12‐ and 24‐h groups, drug concentration of 15 μg/cm² ( p < .005 in both) significantly lowered cell viability. In comparison to the control group, miR‐34a mRNA expression, P53 mRNA expression, and protein expression were all significantly greater in the 24‐h group ( p = .0324, p = .0069, p = .0260, respectively), but survivin mRNA and protein expressions were significantly lower than those in the control group ( p = .0338, p = .0032, respectively). There was a significant decrease in gastric cancer cells in the miR‐34a overexpression group ( p = .0020), a significant increase in P53 mRNA and protein expression compared to the control group ( p = .0080, p = .0121, respectively), and a significant decrease in survivin mRNA and protein expression compared to the control group. ( p = .0213, p = .0069, respectively).

Conclusion

Oxaliplatin inhibits tumor growth, invasion, and metastasis by upregulating miR‐34a, activating the expression of the upstream P53 gene, and driving the downregulation of survivin (P53/miR‐34a/survivin axis) in BGC‐823 gastric cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsMicroRNAsOxaliplatinSurvivinTumor Suppressor Protein p53Gene Expression Regulation, NeoplasticInhibitor of Apoptosis ProteinsHumansCell Line, TumorAntineoplastic AgentsOrganoplatinum CompoundsCell SurvivalSignal TransductionCell ProliferationDisease Progression

Stichwörter der Autor:innen

P53 genegastric cancermiR‐34aoxaliplatinsurvivin gene

Substanzen

MicroRNAsOxaliplatinSurvivinMIRN34 microRNA, humanTumor Suppressor Protein p53BIRC5 protein, humanInhibitor of Apoptosis ProteinsAntineoplastic AgentsOrganoplatinum CompoundsTP53 protein, human

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The First Affiliated Hospital of Baotou Medical College, Baotou, China.
  • Department of Gastrointestinal Surgery, Qi Lu Hospital of Shandong University, Jinan, China.
  • Department of General Surgery, HeNan RongJun Hospital, Xinxiang, China.

ORCID-Profile: Qing-Si He

Förderung

  • Natural Science Foundation of Inner Mongolia Autonomous Region

Zitieren

APA

Guo, Q., Wang, X. Y., Zhai, Y. C., Dong, Y. W., & He, Q. S. (2024). RETRACTED: Oxaliplatin activates P53/miR‐34a/survivin axis in inhibiting the progression of gastric cancer cells. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70004

Vancouver

Guo Q, Wang XY, Zhai YC, Dong YW, He QS. RETRACTED: Oxaliplatin activates P53/miR‐34a/survivin axis in inhibiting the progression of gastric cancer cells. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.70004

BibTeX
@article{Guo2024,
  author = {Guo, Qiang and Wang, Xin-Yuan and Zhai, Yan-Chang and Dong, Yong-Wei and He, Qing-Si},
  title = {RETRACTED: Oxaliplatin activates P53/miR‐34a/survivin axis in inhibiting the progression of gastric cancer cells},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  doi = {10.1002/iid3.70004}
}
Kostenlos starten →